KATHMANDU: The Department of Drug Administration (DDA) has ordered Arya Pharmalab Private Limited to immediately recall the medicine ‘Supramox CV BD’ from the market after one batch was found to be substandard.

In a public notice, the department directed the recall of batch number FSBD 12016, stating that samples collected during routine market monitoring failed quality tests at the National Medicines Laboratory.

According to the notice, the concerned pharmaceutical company and its representatives have been instructed, in line with Section 14 of the Drugs Act, 1978, to immediately stop the sale and distribution of the affected batch, recall it from the market, and submit detailed information to the Department.

The DDA has also urged all concerned parties not to prescribe, sell, distribute, or use ‘Supramox CV BD’ bearing batch number FSBD 12016.